| Metric | Q2 FY27 | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue from operations | 1560.0 | 1476.8 | 1297.0 |
| Other income | 10.7 | 2.3 | -1.1 |
| Total income | 1570.7 | 1479.0 | 1295.8 |
| Profit before exceptional items & tax | 243.4 | 240.4 | 175.9 |
| Profit before tax | 243.4 | 240.4 | 175.9 |
| Net profit | 181.8 | 180.0 | 130.6 |
| Operating margin | 15.5% | 16.3% | 13.6% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +39.20% |
|---|---|
| Net profit, quarter on quarter | +1.00% |
| Revenue, year on year | +20.30% |
| Operating profit, year on year | +31.50% |
| Operating profit, quarter on quarter | -2.30% |
NSE results filing, NSE: GRANULES. Figures extracted from the filing.
Granules India Ltd: key numbers
- Share price
- ₹839.75
- Market cap
- ₹20,809 Cr
- Revenue (annual)
- ₹5,366 Cr
- Net profit (annual)
- ₹595.0 Cr
- P/E (TTM)
- 31.4×Sector 45.9×
- Promoter holding
- 37.39%-0.63% QoQ
- FII holding
- 20.25%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Granules India Ltd
All →Granules India Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹15,600 Mn (+20% YoY), EBITDA ₹3,376 Mn (21.6% margin), PAT ₹1,818 Mn (+39%). Net cash ₹8,280 Mn after warrant proceeds.
Granules India Results Update
Granules India reported Q2FY27 revenue of INR 15,600 Mn, up 20% YoY, and PAT of INR 1,818 Mn, up 39%. The company also cited a net cash position and a US FDA audit at its Gagillapur site.
Granules India Business Update
Granules' Gagillapur facility received eleven USFDA observations with no impact on product supply. The inspection was the first since a February 2025 Warning Letter.
Granules India Convertible Warrants
Chigurupati family promoters disclosed acquiring 2,49,82,906 warrants via preferential allotment on 23 February 2026. Warrants priced at ₹585 each lift diluted promoter-group holding to 43.69%.
- Value
- ₹1,462 Cr
Granules India Convertible Warrants
Promoter group members Uma Devi, Priyanka, Pragnya and Harsha were allotted 2,49,82,906 Granules India shares on warrant conversion. The balance payment totals about ₹1,096.13 crore.
- Value
- ₹1,096 Cr
Granules India Promoter Selling
Promoter Dr Krishna Prasad Chigurupati filed a revised disclosure of selling 1,72,00,000 Granules India shares on 11 September 2026. Promoter group voting stake falls from 38.02% to 31.08%.